Drug Shortage Report for TISSEEL
| Report ID | 229097 |
| Drug Identification Number | 02326132 |
| Brand name | TISSEEL |
| Common or Proper name | TISSEEL Fibrin Sealant – Lyophilized Kit |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | CALCIUM CHLORIDE THROMBIN APROTININ SEALER PROTEIN |
| Strength(s) | 40MCMOL 500UNIT 3000KIU 125MG |
| Dosage form(s) | KIT |
| Route of administration | TOPICAL TOPICAL |
| Packaging size | 1503153 – TISSEEL Fibrin Sealant – Lyophilized Kit – 4ML |
| ATC code | B02BC |
| ATC description | VITAMIN K AND OTHER HEMOSTATICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-05-17 |
| Actual start date | 2024-05-17 |
| Estimated end date | 2024-11-30 |
| Actual end date | 2024-10-25 |
| Shortage status | Resolved |
| Updated date | 2024-11-28 |
| Company comments | Depending on the desired use of the product, Baxter Corporation offers the Fibrin Sealant products. In addition to the Fibrin Sealant options, Baxter also offers other alternative products for hemostasis, sealing or tissue adherence. It is recommended that customers contact their local Baxter Advanced Surgery Representative to discuss their specific clinical needs to determine the best possible alternative for their practice.” |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2024-11-28 | French | Compare |
| v3 | 2024-11-28 | English | Compare |
| v2 | 2024-05-29 | French | Compare |
| v1 | 2024-05-29 | English | Compare |
Showing 1 to 4 of 4